BlackRock’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72K Buy
51,436
+133
+0.3% +$186 ﹤0.01% 4841
2025
Q1
$90.8K Sell
51,303
-27,650
-35% -$48.9K ﹤0.01% 4744
2024
Q4
$182K Buy
78,953
+27,673
+54% +$63.6K ﹤0.01% 4584
2024
Q3
$182K Buy
51,280
+19,995
+64% +$70.8K ﹤0.01% 4494
2024
Q2
$86.7K Buy
+31,285
New +$86.7K ﹤0.01% 4685
2024
Q1
Sell
-189
Closed -$576 5310
2023
Q4
$576 Hold
189
﹤0.01% 5208
2023
Q3
$287 Hold
189
﹤0.01% 5305
2023
Q2
$338 Hold
189
﹤0.01% 5351
2023
Q1
$234 Hold
189
﹤0.01% 5428
2022
Q4
$448 Sell
189
-1
-0.5% -$2 ﹤0.01% 5586
2022
Q3
$1K Hold
190
﹤0.01% 5686
2022
Q2
$1K Sell
190
-9,520
-98% -$50.1K ﹤0.01% 5733
2022
Q1
$100K Sell
9,710
-464
-5% -$4.78K ﹤0.01% 5198
2021
Q4
$114K Buy
10,174
+448
+5% +$5.02K ﹤0.01% 5160
2021
Q3
$198K Sell
9,726
-207
-2% -$4.21K ﹤0.01% 4929
2021
Q2
$249K Buy
+9,933
New +$249K ﹤0.01% 4781
2020
Q2
Sell
-2,322
Closed -$15K 5036
2020
Q1
$15K Sell
2,322
-628
-21% -$4.06K ﹤0.01% 4588
2019
Q4
$34K Sell
2,950
-32
-1% -$369 ﹤0.01% 4529
2019
Q3
$40K Buy
2,982
+508
+21% +$6.81K ﹤0.01% 4514
2019
Q2
$36K Buy
2,474
+1,589
+180% +$23.1K ﹤0.01% 4568
2019
Q1
$35K Sell
885
-54
-6% -$2.14K ﹤0.01% 4478
2018
Q4
$16K Buy
939
+85
+10% +$1.45K ﹤0.01% 4565
2018
Q3
$47K Buy
854
+35
+4% +$1.93K ﹤0.01% 4485
2018
Q2
$88K Sell
819
-10,979
-93% -$1.18M ﹤0.01% 4425
2018
Q1
$1.92M Sell
11,798
-78
-0.7% -$12.7K ﹤0.01% 3645
2017
Q4
$2.5M Buy
11,876
+56
+0.5% +$11.8K ﹤0.01% 3579
2017
Q3
$3.16M Buy
+11,820
New +$3.16M ﹤0.01% 3538